Glycosylation of aesculetin was performed using amylosucrase from the hyperthermophilic bacterium Deinococcus geothermalis DSM 11300 to improve the solubility and biological activity of aesculetin. A newly synthesized aesculetin glycoside was identified as α-cichoriin (aesculetin 7-α-D-glucoside) by nuclear magnetic resonance analysis. The solubility of α-cichoriin was 11 times higher than that of aesculetin because of the attached glucose moiety. Aesculetin and α-cichoriin had no significant effect on the proliferation of normal cells, such as RAW 264.7, but they showed a cell proliferation inhibitory effect on B16F10 melanoma cells. Unlike treatment with aesculetin and α-cichoriin, aesculin (aesculetin 6-β-D-glucoside) showed no antiproliferative activity in B16F10 cells. Based on the molecular structures of aesculin and α-cichoriin, the position where glucose binds to aesculetin and the anomeric configuration between glucose and aesculetin are thought to be important for exerting an antiproliferative effect on the B16F10 cell line. Based on these results, we propose that α-cichoriin, the α-glycosylated form of aesculetin, may serve as a model for developing phytochemical analogs with therapeutic potential for the treatment of diseases associated with tumor cell proliferation without cytotoxicity to normal cells.
1. Liang C, Ju W, Pei S, Tang Y, Xiao Y. 2017. Pharmacological activi-ties and synthesis of esculetin and its derivatives: A minireview.Molecules 22: 387.
2. Kaneko T, Tahara S, Takabayashi F. 2007. Inhibitory effect of natu-ral coumarin compounds, esculetin and esculin, on oxidativeDNA damage and formation of aberrant crypt foci and tumorsinduced by 1,2-dimethylhydrazine in rat colons. Biol. Pharm. Bull.30: 2052-2057.
3. Marinova EM, Yanishlieva NV, Kostova IN. 1994. Antioxidativeaction of the ethanolic extract and some hydroxycoumarins ofFraxinus ornus bark. Food Chem. 51: 125-132.
7. Pan L, Huang YW, Guh JH, Chang YL, Peng CY, Teng CM. 2003.Esculetin inhibits Ras-mediated cell proliferation and attenuatesvascular restenosis following angioplasty in rats. Biochem.Pharmacol. 65: 1897-1905.
8. Finn GJ, Kenealy E, Creaven BS, Egan DA. 2002. In vitro cytotoxicpotential and mechanism of action of selected coumarins, usinghuman renal cell lines. Cancer Lett. 183: 61-68.
9. Kawaii S, Tomono Y, Ogawa K, Sugiura M, Yano M, Yoshizawa Y.2001. The antiproliferative effect of coumarins on several cancercell lines. Anticancer Res. 21: 917-924.
10. Kawase M, Sakagami H, Hashimoto K, Tani S, Hauer H, ChatterjeeSS. 2003. Structure-cytotoxic activity relationships of simplehydroxylated coumarins. Anticancer Res. 23: 3243-3246.
11. Lacy A, O'Kennedy R. 2004. Studies on coumarins and coumarin-related compounds to determine their therapeutic role in thetreatment of cancer. Curr. Pharm. Des. 10: 3797-3811.
13. Park S, Moon K, Park CS, Jung DH, Cha J. 2018. Synthesis of aes-culetin and aesculin glycosides using engineered Escherichia coliexpressing Neisseria polysaccharea amylosucrase. J. Microbiol.Biotechnol. 28: 566-570.
14. Liang SC, Ge GB, Liu HX, Zhang YY, Wang LM, Zhang JW, et al.2010. Identification and characterization of human UDP-glucu-ronosyltransferases responsible for the in vitro glucuronidationof daphnetin. Drug Metab. Dispos. 38: 973-980.
15. Xia YL, Liang SC, Zhu LL, Ge GB, He GY, Ning J, et al. 2014. Identifi-cation and characterization of human UDP-glucuronosyltransfer-ases responsible for the glucuronidation of fraxetin. Drug Metab.Pharmacokinet. 29: 135-140.
16. Zhang SF, Ma JH, Chen SR, Li HY, Xin JF. 2007. Improved synthesistechnics of 6,7-dimethoxy coumarin. J. Hebei Univ. Sci. Technol.28: 24-25.
17. Bull JA, Lujan C, Hutchings MG, Peter Q. 2009. Application of theBHQ benzannulation reaction to the synthesis of benzo-fusedcoumarins. Tetrahedron Lett. 50: 3617-3620.
18. Nemoto T, Ohshima T, Shibasaki M. 2003. Enantioselective totalsyntheses of (+)-decursin and related natural compounds usingcatalytic asymmetric epoxidation of an enon. Tetrahedron 59:6889-6897.
22. Wang X, Li C, Zhou C, Li J, Zhang Y. 2017. Molecular characteriza-tion of the C‐glucosylation for puerarin biosynthesis in Puerarialobata. Plant J. 90: 535-546.
23. Ito T, Fujimoto S, Suito F, Shimosaka M, Taguchi G. 2017.C‐Glycosyltransferases catalyzing the formation of di‐C‐glucosylflavonoids in citrus plants. Plant J. 91: 187-198.
24. Chen D, Chen R, Wang R, Li J, Xie K, Bian C, et al. 2015. Probing thecatalytic promiscuity of a regio‐ and stereospecific C‐glycosyl-transferase from Mangifera indica. J. Angew. Chem. Int. Ed. 54:12678-12682.
25. Chen D, Sun L, Chen R, Xie K, Yang L, Dai J. 2016. Enzymatic syn-thesis of acylphloroglucinol 3‐C‐glucosides from 2‐O‐glucosidesusing a C‐glycosyltransferase from Mangifera indica. Chem. Eur. J.22: 5873-5877.
27. Andersen-Ranberg J, Kongstad KT, Nafisi M, Staerk D, Okkels FT,Mortensen UH, et al. 2017. Synthesis of C‐glucosylated octa-ketide anthraquinones in Nicotiana benthamiana by using a mul-tispecies‐based biosynthetic pathway. ChemBioChem 18: 1893-1897.
28. Salem SM, Weidenbach S, Rohr J. 2017. Two cooperative glycos-yltransferases are responsible for the sugar diversity of saquaya-mycins isolated from Streptomyces sp. KY 40-1. ACS Chem. Biol.12: 2529-2534.
29. Seo DH, Yoo SH, Choi SJ, Kim YR, Park CS. 2020. Versatile biotech-nological applications of amylosucrase, a novel glucosyltransferase.Food Sci. Biotechnol. 29: 1-16.
30. Chiang C-M, Wang T-Y, Wu J-Y, Zhang Y-R, Lin S-Y, Chang T-S.2021. Production of new isoflavone diglucosides from glycosyla-tion of 8-hydroxydaidzein by Deinococcus geothermalis amylosu-crase. Fermentation 7: 232.
31. Rha CS, Kim HG, Baek NI, Kim, DO, Park CS. 2020. Using amylosu-crase for the controlled synthesis of novel isoquercitrin glyco-sides with different glycosidic linkages. J. Agric. Food Chem. 68:13798-13805.
32. Rha CS, Kim ER, Kim YJ, Jung YS, Kim DO, Park CS. 2019. Simpleand efficient production of highly soluble daidzin glycosides byamylosucrase from Deinococcus geothermalis. J. Agric. FoodChem. 67: 12824-12832.
33. Cho HK, Kim HH, Seo DH, Jung JH, Park JH, Baek NI, et al. 2011.Biosynthesis of (+)-catechin glycosides using recombinant amy-losucrase from Deinococcus geothermalis DSM 11300. EnzymeMicrob. Technol. 49: 246-253.
34. Moon YH, Lee JH, Ahn JS, Nam SH, Oh DK, Park DH, et al. 2006.Synthesis, structure analyses, and characterization of novel epi-gallocatechin gallate (EGCG) glycosides using the glucansucrasefrom Leuconostoc mesenteroides B-1299CB. J. Agric. Food Chem.54: 1230-1237.
35. Lee SJ, Kim JC, Kim MJ, Kitaoka M, Park CS, Lee SY, et al. 1999.Transglycosylation of naringin by Bacillus stearothermophilusmaltogenic amylase to give glycosylated naringin. J. Agric. FoodChem. 47: 3669-3674.
36. Ko JA, Ryu YB, Park T, Jeong HJ, Kim JH, Park SJ, et al. 2012. Enzy-matic synthesis of puerarin glucosides using Leuconostoc dex-transucrase. J. Microbiol. Biotechnol. 22: 1224-1229.
37. Moon YH, Lee JH, Jhon DY, Jun WJ, Kang SS, Sim J, et al. 2007.Synthesis and characterization of novel quercetin-α-D-glucopy-ranosides using glucansucrase from Leuconostoc mesenteroides.Enzyme Microb. Technol. 40: 1124-1129.
38. Acero JL, Benitez JF, Real FJ, Leal AI, Sordo A. 2005. Oxidation ofesculetin, a model pollutant present in cork processing wastewa-ters, by chemical methods. Ozone: Sci. Eng. 27: 317-326.
39. Hollman PC, Bijsman MN, van Gameren Y, Cnossen EP, de VriesJH, Katan MB. 1999. The sugar moiety is a major determinant ofthe absorption of dietary flavonoid glycosides in man. Free Radic.Res. 32: 569-573.
40. Jiang JR, Yuan S, Ding JF, Zhu SC, Xu HD, Chen T, et al. 2008. Con-version of puerarin into its 7-O-glycoside derivatives by Micro-bacterium oxydans (CGMCC 1788) to improve its water solubilityand pharmacokinetic properties. Appl. Microbiol. Biotechnol. 81:647-657.
41. Yamada M, Tanabe F, Arai N, Mitsuzumi H, Miwa Y, Kubota M, etal. 2006. Bioavailability of glucosyl hesperidin in rats. Biosci.Biotechnol. Biochem. 70: 1386-1394.
42. Marshall ME, Butler K, Fried A. 1991. Phase I evaluation of coumarin(1,2-benzopyrone) and cimetidine in patients with advancedmalignancies. Mol. Biother. 3: 170-178.
43. Mohler JL, Gomella LG, Crawford ED, Glode LM, Zippe CD, FairWR, et al. 1992. Phase II evaluation of coumarin (1,2-benzopy-rone) in metastatic prostatic carcinoma. Prostate 20: 123-131.
45. Egan D, O'Kennedy R, Moran E, Cox D, Prosser E, Thornes RD.1990. The pharmacology, metabolism, analysis, and applicationsof coumarin and coumarin-related compounds. Drug Metab. Res.22: 503-529.
46. Funayama M, Arakawa H, Yamamoto R, Nishino T, Shin T, MuraoS. 1995. Effects of α- and β-Arbutin on activity of tyrosinases frommushroom and mouse melanoma. Biosci. Biotech. Biochem. 59:143-144.
more references